Human immunodeficiency virus-type 1 infection in an inner-city alcohol treatment program

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 1, 1996, Pages 75-80

  Schleifer, Steven J ^a   Keller, Steven E ^a   LaFarge, Stephanie ^a   Dhaibar, Yeshuschandra ^a   Shiflett, Samuel C ^a   Eckholdt, Haftan M ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Alcohol Dependence; HIV; IDU; Inner City; Prevalence

Indexed keywords

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK;

ADULT; ALCOHOLISM; AMBULATORY CARE; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW JERSEY; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; URBAN POPULATION;

EID: 0029965214     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb01047.x     Document Type: Article

References (15)

1. DesJarlais DC, Friedman SR, Novick DM, Sotheran JL, Thomas P, et al: HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 261:1008-1012, 1989
2. Weiss SH, Ginzburg HM, Godert JJ, et al: Risk of HTLV-III Exposure and AIDS among Parenteral Drugs Abusers in New Jersey. Washington, D.C., International Conference on AIDS, April 1985, p 44
3. Weiss SH, Ginzburg HM, Saxinger WC, et al: Emerging High Rates of Human T-Cell Lymphocytotropic Virus Type I (HTLV-I) and HIV Infection among U.S. Drug Abusers. Washington, D.C., Third International Conference on AIDS, June 1987
4. Schleifer SJ, Keller SE, Lombardo JM, Franklin JE, Lafarge S, Miller SI: HIV-1 antibody reactivity in inner-city alcoholics. JAMA 262:2680-2681, 1989
5. Spitzer RL, Williams JBW, Gibbons M: Structured Clinical Inter-view for DSM-III-R, Non-patient Version (SCID-NP 4/1/87). New York, Biometrics Research Department, New York State Psychiatric Institute, 1987
6. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). Washington, D.C., American Psychiatric Association, 1987
7. Avins AL, Woods WJ, Lindan CP, Hudes ES, Clark W, Hulley SB: HIV infection and risk behaviors among heterosexuals in alcohol treatment programs. JAMA 271:515-518, 1994
8. Lombardo JM, Kloser P, Pawel BR, Trost R, Kapila R: Sentinel hospital surveillance for HIV-1 antibody versus clinical laboratory submissions in University Hospital. Montreal, Quebec, Canada, Fifth International Conference on AIDS, June 5, 1989
9. Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE: Seroprevalence of HTLV-1 and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 326:375-380, 1992
10. Centers for Disease Control and Prevention: Heterosexually acquired AIDS - United States, 1993. MMWR 43:155-160, 1994
11. Crowe LC, George WH: Alcohol and human sexuality: Review and integration. Psychol Bull 105:374-386, 1989
12. Hearst N, Hulley SB: Preventing the heterosexual spread of AIDS: Are we giving our patients the best advice? JAMA 259:2428-2432, 1988
13. Cameron DW, Simonsen JN, D'Costa LJ, Ronald AR, Maitha GM, Gakinya MN, Cheang M, Ndinya-Achola JO, Piot P, Brunham RC, Plummer FA: Female to male transmission of human immunodeficiency virus type 1: Risk factors for seroconversion in men. Lancet 403-408, 1989
14. Padian NS, Shiboski SC, Jewell NP: Female-to-male transmission of human immunodeficiency virus. JAMA 266:1664-1667, 1991
15. Kennedy CA, Skurnick J, Wan JY, Quattrone G, Sheffet A, Quinones M, Wang W, Louria DB: Psychological distress, drug and alcohol use as correlates of condom use in HIV-serodiscordant heterosexual couples. AIDS 7:1493-1499, 1993